Recombinant Human Jagged 1 Fc Chimera Protein, CF Best Seller
R&D Systems, part of Bio-Techne | Catalog # 1277-JG
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Human Jagged 1 (Ser32-Ser1046) Accession # P78504 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.5-2.0 μg/mL.
Reviewed Applications
Read 2 reviews rated 5 using 1277-JG in the following applications:
Formulation, Preparation and Storage
1277-JG
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS and EDTA. |
Reconstitution |
Reconstitute at 200 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Jagged 1
Jagged 1 is a 180 kDa type I transmembrane glycoprotein and member of the Delta-Serrate-Lag-2 (DSL) family of ligands that activate LIN12/Notch proteins. Human Jagged 1 is synthesized as a 1218 amino acid (aa) precursor that contains a 33 aa signal sequence, a 1034 aa extracellular domain (ECD), a 26 aa transmembrane segment, and a 125 aa cytoplasmic region (SwissProt # P78504). The ECD contains a DSL domain (aa 185-229), a cysteine-rich region, 15 EGF-like repeats, of which many bind calcium, and nine potential sites for N-linked glycosylation. Mature human Jagged 1 is 97% and 96% aa identical to mature mouse and rat Jagged 1, respectively. Jagged 1 is widely expressed in adult and fetal tissues. Jagged-Notch signaling specifies cell fate, regulates pattern formation, defines boundaries between different cell types, and modulates cell proliferation and differentiation, especially during hematopoiesis, myogenesis, neurogenesis, and development of vasculature (1-8). Mutations in human Jagged 1 are the cause of Alagille syndrome, an autosomal-dominant disorder characterized by intrahepatic cholestasis and abnormalities of heart, eye, vertebrae, as well as characteristic facial appearance (9-10).
References
- Sainson, R.C. and A.L. Harris (2008) Angiogenesis 11:41.
- Cordle, J. et al. (2008) Nat. Struct. Mol. Biol. 15:849.
- Artavamis-Tsokanas, S. et al. (1999) Science 284:770.
- Lai, E.C. (2004) Development 131:965.
- Milner, L.A. et al. (1994) Blood 83:2057.
- Nyfeler, Y. et al. (2005) EMBO J. 24:3504
-
Linheng, L. et al. (1998) Immunity 8:43.
-
Iso, T. et al. (2003) Arterioscler. Thromb. Vasc. Biol. 23:543.
-
Oda, T. et al. (1997) Nat. Genet. 16:235.
-
Oda, T. et al. (1997) Genomics 43:376.
Alternate Names
Gene Symbol
UniProt
Additional Jagged 1 Products
Product Documents for Recombinant Human Jagged 1 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Human Jagged 1 Fc Chimera Protein, CF
For research use only